期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
CaO和方解石钝化不同污染程度煤矸石性能与机理
1
作者 张华林 江晓亮 +1 位作者 赵梦飞 李庭刚 《科学通报》 EI CAS CSCD 北大核心 2024年第4期617-629,共13页
煤矸石是一种典型的工业废弃物,大量的煤矸石堆积会造成各种环境问题以及资源浪费.在环境问题中,重金属污染最为严重.本文采用CaO和方解石对不同污染程度的煤矸石中重金属进行钝化,并探究其钝化机理.结果表明,CaO和方解石均有较好的钝... 煤矸石是一种典型的工业废弃物,大量的煤矸石堆积会造成各种环境问题以及资源浪费.在环境问题中,重金属污染最为严重.本文采用CaO和方解石对不同污染程度的煤矸石中重金属进行钝化,并探究其钝化机理.结果表明,CaO和方解石均有较好的钝化效果,能使中高度污染的煤矸石转化为轻度污染或无污染,CaO钝化Pb^(2+)、Zn^(2+)、Cu^(2+)的平均钝化率分别为37.4%、37.8%、25.5%;方解石钝化Pb^(2+)、Zn^(2+)、Cu^(2+)的平均钝化率分别为53.8%、43.5%、34.4%,方解石钝化效果略优于CaO.通过对钝化前后煤矸石的表征和Visual MINTEQ软件模拟,CaO可以通过提高煤矸石pH并提供OH^(−),与重金属离子结合生成难溶或不溶的氢氧化物沉淀;方解石不仅能提高体系的pH,还能提供CO_(3)^(2−),CO_(3)^(2−)与重金属离子结合生成难溶或不溶的碳酸盐.两者钝化均将煤矸石中可流动态重金属转化成残渣态重金属.对钝化前后的煤矸石进行模拟酸雨溶出实验,钝化后的煤矸石中各重金属成分较稳定,溶出风险明显低于原煤矸石,均在风险管控标准以下.综上,该方法能有效地钝化煤矸石中的重金属,为煤矸石的无害化,尤其是重金属污染的稳定化提供了有效的手段. 展开更多
关键词 煤矸石 重金属 钝化 VISUAL MINTEQ模拟
原文传递
A non-human primate derived anti-P-selectin glycoprotein ligand-1 antibody curtails acute pancreatitis by alleviating the inflammatory responses
2
作者 Yuhan Li Xiangqing Ding +8 位作者 Xianxian Wu Longfei Ding Yuhui Yang xiaoliang jiang Xing Liu Xu Zhang Jianrong Su Jianqing Xu Zhiwei Yang 《Acta Pharmaceutica Sinica B》 SCIE CAS CSCD 2023年第11期4461-4476,共16页
Acute pancreatitis(AP)is a devastating disease characterized by an inflammatory disorder of the pancreas.P-selectin glycoprotein ligand-1(PSGL-1)plays a crucial role in the initial steps of the adhesive at process to ... Acute pancreatitis(AP)is a devastating disease characterized by an inflammatory disorder of the pancreas.P-selectin glycoprotein ligand-1(PSGL-1)plays a crucial role in the initial steps of the adhesive at process to inflammatory sites,blockade of PSGL-1 might confer potent anti-inflammatory effects.In this study,we generated two non-human primate derived monoclonal antibodies capable of efficiently targeting human PSGL-1,RH001-6 and RH001-22,which were screened from immunized rhesus macaques.We found that RH001-6,can effectively block the binding of P-selectin to PSGL-1,and abolish the adhesion of leukocytes to endothelial cells in vitro.In vivo,we verified that RH001-6 relieved inflammatory responses and pancreatic injury in both caerulein and L-arginine induced AP models.We also evaluated the safety profile after RH001-6 treatment in mice,and verified that RH001-6 did not cause any significant pathological damages in vivo.Taken together,we developed a novel non-human primate derived PSGL-1 blocking antibody with high-specificity,named RH001-6,which can interrupt the binding of PSGL-1 and P-selectin and attenuate inflammatory responses during AP.Therefore,RH001-6 is highly potential to be further developed into therapeutics against acute inflammatory diseases,such as AP. 展开更多
关键词 Acute pancreatitis PSGL-1 Non-human primate Monoclonal antibody Therapeutic antibody RH001-6 Adhesion of leukocytes to endothelial cells Inflammatory responses Pancreatic injury
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部